Peter Alfinito, PhD
Peter Alfinito, PhD, is an Executive Director, Operational Strategy & Planning of CVMER (cardiovascular, metabolic, endocrine and renal) at Fortrea. Dr Alfinito has more than 22 years of experience in academic research, drug discovery and clinical development, including 8 years of specific cardio-metabolic and liver disease focus. Dr. Alfinito supports global clinical strategies and shares planning expertise across Phases I-IV trials. He specializes in late-phase studies IIb-III/IV studies and is an internationally recognized expert in liver diseases with more than 50 peer-reviewed publications.
Dr. Alfinito has a PhD in Biomedical Science and Neuroscience from Rutgers University of Medicine and Dentistry of New Jersey and a BA in Chemistry from Swarthmore College.
